| BP |
GO:0002449 |
Lymphocyte-mediated immunity |
4.15E-91 |
131 |
| BP |
GO:0006959 |
Humoral immune response |
1.15E-90 |
131 |
| BP |
GO:0002460 |
Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
3.01E-86 |
128 |
| BP |
GO:0006958 |
Complement activation, classical pathway |
1.90E-82 |
85 |
| BP |
GO:0002455 |
Humoral immune response mediated by circulating immunoglobulin |
1.91E-82 |
88 |
| CC |
GO:0019814 |
Immunoglobulin complex |
3.12E-99 |
122 |
| CC |
GO:0042101 |
T-cell receptor complex |
2.74E-98 |
90 |
| CC |
GO:0098802 |
Plasma membrane receptor complex |
1.57E-80 |
111 |
| CC |
GO:0009897 |
External side of plasma membrane |
3.00E-75 |
120 |
| CC |
GO:0042571 |
Immunoglobulin complex, circulating |
1.33E-51 |
49 |
| MF |
GO:0048018 |
Receptor ligand activity |
4.71E-97 |
197 |
| MF |
GO:0003823 |
Antigen binding |
1.67E-94 |
94 |
| MF |
GO:0005125 |
Cytokine activity |
6.20E-86 |
100 |
| MF |
GO:0008083 |
Growth factor activity |
1.18E-68 |
78 |
| MF |
GO:0005126 |
Cytokine receptor binding |
4.80E-65 |
94 |
| KEGG |
hsa04060 |
Cytokine–cytokine receptor interaction |
1.84E-98 |
136 |
| KEGG |
hsa04061 |
Viral protein interaction with cytokine and cytokine receptor |
5.58E-36 |
50 |
| KEGG |
hsa04080 |
Neuroactive ligand–receptor interaction |
4.31E-27 |
76 |
| KEGG |
hsa04062 |
Chemokine signaling pathway |
1.05E-16 |
45 |
| KEGG |
hsa04650 |
Natural killer cell–mediated cytotoxicity |
2.39E-16 |
37 |
